Stay updated with breaking news from Schulhoff Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the […]
StockNews.com assumed coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a report released on Saturday. The brokerage issued a buy rating on the stock. Several other equities analysts have also recently weighed in on FUN. Morgan Stanley increased their price target on Cedar Fair from $50.00 to $55.00 and gave the company […]
StockNews.com assumed coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a report released on Friday. The brokerage issued a buy rating on the stock. Several other equities analysts have also weighed in on FUN. Stifel Nicolaus cut their price target on Cedar Fair from $51.00 to $49.00 and set a buy rating […]
StockNews.com initiated coverage on shares of Cedar Fair (NYSE:FUN – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a buy rating on the stock. Several other research firms also recently weighed in on FUN. Stifel Nicolaus decreased their price target on shares of Cedar Fair from $51.00 to $49.00 […]